Teva Pharmaceuticals

Winner: Best Integrated Working Capital Project

Key Facts

  • Use of supply chain finance programmes to improve working capital management
  • Successfully negotiated new payment terms for more than 600 suppliers with $1.5 billion spend and unlocked cash flow of $130 million.
  • Aims to improve DPO by 15 days by the end of 2023

What the judges said

​“This case outlines the importance of changing the mindset across departments or hierarchies to optimise working capital. Teva seems to have had this spark during the pandemic months where working capital and liquidity became a central topic.”

You have reached your monthly limit of articles. Register now for free unlimited access!
Login Join Now

Global sponsor